Shigella

One additional death related to shigella has been reported in Kerala, along with seven new cases. The outbreak continues to be a public health concern in the region.

A Shigella alert has been issued in Thrissur. The situation is being monitored to prevent outbreaks.

Kerala is developing an 'outbreak calendar' to enhance disease prediction and response. Health Minister K. Muraleedharan attributes the current Shigella outbreak to inadequate monsoon cleaning.

Malappuram has intensified surveillance for Nipah and Shigella. Officials confirmed four contacts are in the low-risk category and advised the public against spreading rumors on social media.

Shigella cases have been detected in Wadakkanchery municipality, with two children infected. The Health Department has intensified surveillance and preventive measures in response to the outbreak.

Seven additional Shigella cases have been confirmed in Wayanad, Kerala. The District Medical Officer, K.T. Rekha, announced enhanced infectious disease surveillance and preventive measures in the district.

Monsoons have caused a surge in fever and infectious diseases in Kerala's central Travancore region. Health authorities warn of rising threats from shigella, H1N1, dengue, leptospirosis, and other waterborne illnesses.

The health department in Kollam has intensified surveillance following the confirmation of two Shigella cases in children aged 6 and 8. Both children are stable and receiving treatment, with officials urging strict hygiene practices and safe drinking water to prevent further spread.

The Kerala government has intensified preventive measures against Shigella, with Food Safety officials instructed to inspect restaurants and wayside eateries to ensure compliance with food safety norms.

Antibiotic-resistant Shigella infections have increased substantially in the U.S. from 2011 to 2023, with 8.5% of cases resistant to common antibiotics by 2023. The CDC reported findings in its Morbidity and Mortality Weekly Report, highlighting the spread of drug-resistant strains within the U.S. and the lack of FDA-approved treatments for resistant cases.